Aarti Drugs Ltd
NSE:AARTIDRUGS

Watchlist Manager
Aarti Drugs Ltd Logo
Aarti Drugs Ltd
NSE:AARTIDRUGS
Watchlist
Price: 396.6 INR -0.29% Market Closed
Market Cap: 36.2B INR

Aarti Drugs Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Aarti Drugs Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Aarti Drugs Ltd
NSE:AARTIDRUGS
Net Income (Common)
₹2B
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
10%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
₹57.7B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Net Income (Common)
₹54.4B
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
₹104.5B
CAGR 3-Years
37%
CAGR 5-Years
48%
CAGR 10-Years
14%
Lupin Ltd
NSE:LUPIN
Net Income (Common)
₹43.2B
CAGR 3-Years
299%
CAGR 5-Years
N/A
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
₹21.4B
CAGR 3-Years
39%
CAGR 5-Years
12%
CAGR 10-Years
4%
No Stocks Found

Aarti Drugs Ltd
Glance View

Market Cap
36.2B INR
Industry
Pharmaceuticals

Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,450 full-time employees. The Company, through its wholly-owned subsidiary Pinnacle Life Science Private Limited, is focused on producing formulations. The Company’s products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole and Ofloxacin. Its pharma intermediates products are Tinidazole, Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide and Raloxifene. The company also offers specialty chemicals, such as Benzene Sulphonyl Chloride and Methyl Nicotinate. The Company’s products under development include Alcoholism Treatment, Anticoagulant, Antihyperphosphatemia, Anti-cholestrol, Cardiovascular, Cardiprotectant and Antidiabetic.

AARTIDRUGS Intrinsic Value
637.91 INR
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Aarti Drugs Ltd's Net Income (Common)?
Net Income (Common)
2B INR

Based on the financial report for Sep 30, 2025, Aarti Drugs Ltd's Net Income (Common) amounts to 2B INR.

What is Aarti Drugs Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%

Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for Aarti Drugs Ltd have been 2% over the past three years , -4% over the past five years , and 10% over the past ten years .

Back to Top